“…Thus, accurate determination of the presence and degree of liver fibrosis is of paramount importance in choosing treatment strategies, evaluating responses to treatment, assessing the risk of developing liver-related complications, and predicting prognosis in CLD patients. As a surrogate for liver biopsy (LB), which is an invasive procedure and is often subject to not only sampling error but also intra- and inter-observer variability in histological interpretation [3,4,5,6,7], liver stiffness (LS) measurement using transient elastography (TE) was introduced as a promising non-invasive method for assessing liver fibrosis [8,9,10,11,12,13]. In many studies, TE proved reliable and accurate in terms of predicting significant fibrosis or cirrhosis [14,15,16,17,18,19].…”